Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Nantahala Capital Management, LLC reported a 9.99% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Nantahala Capital Management, LLC reported a 9.99% stake in Vistagen Therapeutics, Inc., 3,185,564 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 3,185,564
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 3,185,564 |
| Wilmot B. Harkey | 9.99% | 3,185,564 |
| Daniel Mack | 9.99% | 3,185,564 |
Source
Related
- Vistagen Therapeutics, Inc.
- Nantahala Capital Management, LLC
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Feb 13, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026